Valoctocogene roxaparvovec
270-205
Phase 2 mab active
Quick answer
Valoctocogene roxaparvovec for Hemophilia A With Inhibitor is a Phase 2 program (mab) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Hemophilia A With Inhibitor
- Phase
- Phase 2
- Modality
- mab
- Status
- active